ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $325,000 | -63.5% | 38,866 | -61.0% | 0.01% | -68.2% |
| Q1 2017 | $891,000 | +11.7% | 99,698 | +9.8% | 0.04% | -31.2% |
| Q4 2016 | $798,000 | +144.0% | 90,781 | -1.1% | 0.06% | +236.8% |
| Q2 2016 | $327,000 | -17.2% | 91,754 | -31.4% | 0.02% | -29.6% |
| Q1 2016 | $395,000 | -55.4% | 133,841 | -36.2% | 0.03% | -55.7% |
| Q4 2015 | $885,000 | -16.4% | 209,676 | +42.8% | 0.06% | +3.4% |
| Q2 2015 | $1,059,000 | +129.7% | 146,834 | +135.0% | 0.06% | +110.7% |
| Q1 2015 | $461,000 | -51.2% | 62,493 | -68.7% | 0.03% | -63.6% |
| Q4 2014 | $945,000 | – | 199,761 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |